In the present study, we investigated whether 5-HT4R activation ameliorates diabetes-driven TJ barrier dysfunction by inhibiting MLC phosphorylation mediated by either MLCK or ROCK1. The gene discussed is MYLK3; the disease is diabetes mellitus.